Fennec Pharmaceuticals
FENC
43 hedge funds and large institutions have $120M invested in Fennec Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 5 closing their positions.
1,227% more call options, than puts
Call options by funds: $3.09M | Put options by funds: $233K
260% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 5
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
39% more funds holding
Funds holding: 31 → 43 (+12)
30% more capital invested
Capital invested by funds: $92.1M → $120M (+$27.5M)
3.81% more ownership
Funds ownership: 43.6% → 47.42% (+3.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.41M |
| 2 |
GJL
Gendell Jeffrey L
|
+$1.35M |
| 3 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
+$1.13M |
| 4 |
SCM
Solas Capital Management
Darien,
Connecticut
|
+$1.07M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$952K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.08M |
| 2 |
6CM
683 Capital Management
New York
|
-$751K |
| 3 |
VFIC
Valley Forge Investment Consultants
Audubon,
Pennsylvania
|
-$324K |
| 4 |
WANY
Wealthspire Advisors (New York)
New York
|
-$202K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$132K |
FENC Hedge Fund Activity: Q4 2022 in Review
43 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q4 2022, worth a combined $120M — up 30% from $92.1M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new FENC positions and 5 closed out — a net gain of 13 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Opaleye Management, opening a new position worth an estimated $2.41M. The largest seller was Millennium Management, cutting an estimated $1.08M.
- 43 institutional investors held Fennec Pharmaceuticals (FENC) as of Q4 2022, up from 31 in Q3 2022.
- Funds reported $120M of Fennec Pharmaceuticals stock for Q4 2022, up 30% quarter-over-quarter.
- 18 funds opened new Fennec Pharmaceuticals positions in Q4 2022 and 5 closed out, a net change of +13 holders.
- The largest Fennec Pharmaceuticals buyer in Q4 2022 was Opaleye Management, an estimated $2.41M added.
- The largest Fennec Pharmaceuticals seller in Q4 2022 was Millennium Management, an estimated $1.08M sold.
Based on aggregated 13F filings for Q4 2022.